New Product: CatchPoint cAMP Detection Assay Kit
Posted: Saturday, January 26, 2013 Location: Sunnyvale, California, USA
Contact the Company
Ad Details - #463826
LabX Member since January 2011.
Molecular Devicesr is one of the world's leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics.
Molecular Devices is committed to the continual development of innovative solutions for life science applications. The Company is headquartered in Silicon Valley with offices around the globe.
Hits: 6646 | Views: 600
The CatchPoint cyclic-AMP Assay Kit measures cAMP levels via a competitive immunoassay format offering high sensitivity and flexible readout times.
Cell signaling via G protein-coupled receptors (GPCRs) can be assessed by monitoring the downstream effectors calcium or cyclic AMP (cAMP). Monitoring levels of cAMP, a second messenger produced in response to activation of adenylate cyclase, is one of the most common ways to screen for agonists and antagonists of GPCRs.
The CatchPoint® cyclic-AMP Assay Kit's high-affinity reagents are optimized for sensitivity and precision in applications where cAMP levels are low. A single wash step removes unbound material prior to the development step, so the assay is very resistant to interference from colored or fluorescent test compounds. The proprietary Stoplight RedTM substrate is used to generate a stable fluorescent readout, allowing the assay to be read in as little as 10 minutes or up to 24 hours after substrate addition.
Benefits of the CatchPoint cyclic-AMP Assay Kit
Molecular Devices, LLC is a LabX Sponsor.